Currently, the heterologous prime-boost regimen has achieved the best results in terms of a strong, protective immune response mediated by CD8+ T cells specific for the pre-erythrocytic stages of malaria parasites (Hill, 2011; Soares et al., 2012; Teixeira et al., 2014). This evidence concerns the gene CD8A and malaria.